0001209191-20-013037.txt : 20200226 0001209191-20-013037.hdr.sgml : 20200226 20200226163736 ACCESSION NUMBER: 0001209191-20-013037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20656335 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Controller Common Stock 2020-02-24 4 F 0 864 239.23 D 16012 D Common Stock 2020-02-25 4 S 0 283 229.66 D 15729 D Common Stock 2020-02-25 4 S 0 137 231.17 D 15592 D Common Stock 2020-02-25 4 S 0 120 232.40 D 15472 D Common Stock 2020-02-25 4 S 0 150 234.50 D 15322 D Common Stock 2020-02-25 4 S 0 150 235.49 D 15172 D Common Stock 2020-02-25 4 S 0 90 236.85 D 15082 D Common Stock 2020-02-25 4 S 0 150 238.40 D 14932 D Common Stock 169 I 401(k) Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $229.66 (range $229.20 to $230.14). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $231.17 (range $230.73 to $231.47). Open market sales reported on this line occurred at a weighted average price of $232.40 (range $232.37 to $232.44). Open market sales reported on this line occurred at a weighted average price of $234.50 (range $234.14 to $235.10). Open market sales reported on this line occurred at a weighted average price of $235.49 (range $235.15 to $235.87). Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.65 to $237.24). Open market sales reported on this line occurred at a weighted average price of $238.40 (range $238.19 to $238.54). /s/ Omar White, Attorney-in-Fact 2020-02-26